Month: September 2020

Opaganib hemmte die Replikation des SARS-CoV-2-Virus vollständig, gemessen nach dreitägiger Inkubation in einem In-vitro-Modell von menschlichem Bronchialgewebe, wobei ein Vergleich mit Remdesivir, der Positivkontrolle in der Studie, positiv ausfiel—Opaganib ist einzigartig positioniert als eine oral verabreichte potenzielle COVID-19-Behandlung, die starke antivirale und entzündungshemmende Wirkmechanismen kombiniert, auf eine Wirtszellkomponente abzielt und die Wahrscheinlichkeit einer Resistenz minimiert—Laufende globale klinische Studie der Phase II/III und laufende klinische Studie der Phase II in den USA mit Opaganib zur Behandlung schwerer COVID-19-Pneumonie —Der zweite Wirkstoffkandidat bezüglich COVID-19 von RedHill, RHB-107 (Upamostat), ein neuer Serinprotease-Inhibitor, erzielte im gleichen Modell eine starke...

Share Buyback Transaction Details September 3 – 9, 2020September 10, 2020 – Wolters Kluwer today reports that it has repurchased 110,300 of its own ordinary shares in the period from September 3, 2020, up to and including September 9, 2020, for €7.7 million and at an average share price of €69.47.These repurchases are part of the share buyback program announced on February 26, 2020, under which we intend to repurchase shares for up to €350 million during 2020.The cumulative amounts repurchased to date under this program are as follows:Share Buyback 2020For the period starting August 6, 2020, up to and including October 28, 2020, we have engaged a third party to execute €100 million of buybacks on our behalf, within the limits of relevant laws and regulations (in particular Regulation (EU) 596/2014) and the company’s Articles...

Hermed offentliggøres dokument med investorinformation iht. § 62 i lov om forvaltere af alternative investeringsfonde m.v. på afdelingen European High Yield KL.Afdelingen vil blive optaget til handel på Nasdaqs delmarked for investeringsbeviser mandag den 14. september 2020.Afdelingen har 75 investorer. Afdelingen har d.d. udstedt 111.089 beviser og har en formue på 112.031.892 DKK. Formuen er etableret i perioden 24. juni 2020 til d.d. i form af emissioner til investorerne.ISIN: DK0061149036Short name: ACKEHYCFI code: CEOGBSFISN code: KAIEUHIYAKKK/-Kontaktperson:Direktør Caspar Møller, tlf. +45 3332 7070.Yderligere oplysninger om Kapitalforeningen Accunia Invest findes på www.accunia-invest.dk.Attachment§62-dok – EuroHY – AccInvKF (sep’20 – final)

Axfood has previously contracted Westpay with the responsibility to provide Axfood with next-generation payment solutions. The initial order value amounts to SEK 20 million during the coming three years starting early 2020 (as communicated 6th February 2020).Last week the project passed a key milestone. Starting now, consumers can experience Westpay’s solutions in selected Axfood stores.A project of this size is always a challenge. But thanks to the commitment, know-how, and customer teamwork, we stay on plan and are now enabling the first pilot in-store.  There are still things on the “to-do list”, but this milestone is a huge step that will prove the quality and stability in our solution. We at Westpay are looking forward to continuing enabling Axfood even more as we expand our footprint in their stores, says Sten Karlsson,...

MELBOURNE, Australia, Sept. 10, 2020 (GLOBE NEWSWIRE) — CLINUVEL PHARMACEUTICALS LTD today announced the progression of its drug SCENESSE® (afamelanotide 16mg) to treat the disease xeroderma pigmentosum (XP). The aim of the development program is to confirm the drug’s ability to regenerate DNA of skin exposed to ultraviolet (UV) damage.1Skin incurs DNA damage following UV exposure. Non-ionising light penetrates the nucleus of skin cells and causes distortions to the DNA helix known as photoproducts. If left unrepaired, these chemical changes to DNA may replicate as mutations, leading to irreversible damage (photoaging) and further progress to skin cancer, including melanoma.Human biology contains complex mechanisms to protect itself from UV damage and restore cellular DNA to its original state. People of fair-skinned complexion...

The net asset value (NAV) of EfTEN Real Estate Fund III AS as of 31.08.2020 was 16.22 euros, increasing by 0.8% in August. The net asset value of the EPRA share (net book value excluding deferred income tax liability and fair value of interest rate derivatives) as of 31.08.2020 was 17.29 euros. EPRA NAV increased 0.9% during August.August was the most successful month in the history of the fund in terms of both sales revenue and EBITDA.In August, EfTEN Real Estate Fund III AS earned a total of 950 thousand euros in sales revenue, ie 94 thousand euros more than in July. The Fund’s August results included, for the first time, rental income from the Atea office building in Vilnius in the amount of 41 thousand euros (calculated for 18 days), as well as temporary rent discounts in DSV Estonia and DSV Lithuania logistics centers ended....

EfTEN Real Estate Fund III AS-i aktsia puhasväärtus (NAV) seisuga 31.08.2020 oli 16,22 eurot, suurenedes augustis 0,8%. EPRA aktsia puhasväärtus (raamatupidamislik puhasväärtus ilma edasilükkunud tulumaksukohustust ja intressiderivatiivide õiglast väärtust arvestamata) oli 31.08.2020 seisuga 17,29 eurot. EPRA NAV suurenes augusti jooksul 0,9%.August oli nii müügitulu kui ka EBITDA näitajate osas edukaim kuu terve fondi ajaloo jooksul. EfTEN Real Estate Fund III AS teenis augustis müügitulu kokku 950 tuhat eurot, s.o 94 tuhat eurot rohkem kui juulis. Fondi augustikuu tulemused sisaldasid esmakordselt Vilniuses asuva Atea büroohoone üüritulu summas 41 tuhat eurot (arvestatud 18 päeva eest), samuti  lõppesid ajutised üüri allahindlused DSV Eesti ja DSV Leedu logistikakeskustes. Fondi EBITDA oli augustis 767 tuhat eurot (69 tuhat eurot rohkem...

SINGAPORE, Sept. 10, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced its presentation at the H.C. Wainwright 22nd Annual Global Investment Conference. Dr Carl Firth, Chief Executive Officer is scheduled to make a company presentation on 16 September 2020 at 9:00am EDT. The virtual conference will be held from 14-16 September 2020.The presentation deck used at the conference will be available in the Investors section of ASLAN’s website at www.aslanpharma.com following the event.Media and IR contactsAbout ASLAN PharmaceuticalsASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments...

Fingrid OyjStock Exchange release 10 September 2020 at 10:00 EETFingrid keeps main grid service fees unchangedMain grid service fees will remain unchanged in 2021. Fingrid has succeeded in operating cost-efficiently and keeping its pricing low, although the transformation of the power system has substantially increased the need for investments in the main grid. Fingrid has been able to reduce its fees by more than ten per cent since 2017. Transmission reliability has not been compromised despite the high level of cost-efficiency. The main grid and the cross-border connections to Finland’s neighbouring countries operate reliably.By international standards, Fingrid is a high-quality, cost-efficient transmission system operator. Fingrid has been highly successful in European comparisons of the prices charged by European transmission system...

Fingrid Oyjpörssitiedote 10.9.2020 kello 10:00 EETFingrid pitää kantaverkkopalvelumaksut ennallaanKantaverkkopalvelumaksut pysyvät vuonna 2021 ennallaan. Fingrid on onnistunut kustannustehokkaalla toiminnallaan pitämään hinnoittelunsa edullisena, vaikka sähköjärjestelmän murros on lisännyt merkittävästi investointitarpeita kantaverkkoon. Maksuja on pystytty laskemaan vuodesta 2017 yli kymmenen prosenttia. Kustannustehokkuudesta huolimatta sähkön siirtovarmuus on erinomaisella tasolla. Kantaverkko ja siirtoyhteydet naapurimaihin toimivat luotettavasti.Fingrid on kansainvälisesti mitattuna laadukas ja kustannustehokas kantaverkkoyhtiö. Fingrid on menestynyt erinomaisesti eurooppalaisten kantaverkkoyhtiöiden hinnoitteluvertailussa ja kunnossapidon tehokkuutta mittaavassa maailmanlaajuisessa vertailussa. Yhtiö on keskittynyt sen perustehtävään...